Accelerated Enrollment Solutions (AES)
Here’s how AES has changed the traditional site/patient model:
- Patient Enrollment Certainty. We don’t rely on sites for patients. Through PatientAdvantage, we identify actual patients in our database in advance of your study start-up, which enables us to precisely predict enrollment numbers and costs.
- Patient Voice. We routinely survey patients in our 100 million-household database of opted in, fully identified patients to help inform study designs, gauge attitudes toward trial participation and recruit for studies.
- Global site organization. We wholly own or partner with 180+ global research sites under a single AES infrastructure to expedite study start-up without lengthy negotiations or contracts.
- Price Certainty. Through PatientAdvantage, we provide a single, fixed, price-per-patient at consent or randomization, including all direct and indirect fees. You don’t pay if we don’t deliver.
Eliminating financial risk
Because we know the patients and we centrally manage the site organization, we can accurately forecast and deliver the timelines and pricing we promise. This virtually eliminates the usual uncertainty surrounding patient numbers, site performance, enrollment timelines and costs.
We precisely calculate costs up front to offer you a per-patient price at consent or randomization, with no added direct or indirect fees.
Over the last five years, AES has successfully supported over 750+ trials for a wide variety of pharmaceutical and biotech companies, accelerating timelines and bending the time-cost curve for now-approved products.
with specific diseases and related risk factors are sourced from our proprietary database of 100 million households
algorithm identifies “lookalike” patients who meet the exact demographic traits of those who have successfully randomized to your trial, expanding your patient pool
geotargets these candidates and the public at large via digital marketing, social media and traditional outreach
undergo extensive prescreening online, by phone or via on-site health screenings to predetermine eligibility prior to study-specific consent